Photodynamic Therapy with Verteporfin for Subfoveal Choroidal Neovascularization in Vogt-Koyanagi-Harada Syndrome.
- Author:
Won Hyuck OH
1
;
Hyeong Gon YU
;
Hum CHUNG
Author Information
1. Department of Ophthalmology, Seoul National University College of Medicine, Korea. hgonyu@snu.ac.kr
- Publication Type:Case Report
- Keywords:
Choroidal neovascularization;
Photodynamic therapy;
Verteporfin;
Vogt-Koyanagi-Harada syndrome
- MeSH:
Choroid*;
Choroidal Neovascularization*;
Fibrosis;
Humans;
Inflammation;
Male;
Middle Aged;
Photochemotherapy*;
Retinal Pigment Epithelium;
Uveomeningoencephalitic Syndrome*;
Visual Acuity
- From:Journal of the Korean Ophthalmological Society
2004;45(5):869-874
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: We present a case of photodynamic therapy (PDT) with verteporfin for choroidal neovascularization (CNV) complicated by Vogt-Koyanagi-Harada syndrome. METHODS: A 46-year-old male who had bilateral subfoveal CNV complicated by Vogt-Koyanagi-Harada syndrome underwent 3 sessions of PDT with verteporfin in 1 year. RESULTS: After 3 sessions of PDT with verteporfin, maintenance of visual acuity was achieved without any complication as alteration of retinal pigment epithelium and aggravation of intraocular inflammation, but subfoveal fibrosis developed. CONCLUSIONS: PDT with verteporfin is a good treatment method without any complication for the CNV complicated by Vogt-Koyanagi-Harada syndrome, even though multiple sessions were needed.
